⌘K

Home/Filings/4/0001209191-23-000232

4//SEC Filing

Goncalves Joana 4

Accession 0001209191-23-000232

CIK 0001346830other

View on SEC.gov Company Profile

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 4:32 PM ET

Size

4.9 KB

Accession

0001209191-23-000232

Insider Transaction Report

Form 4

Period: 2022-12-29

Cara Therapeutics, Inc.CARA

Goncalves Joana

Chief Medical Officer

Transactions

Sale
Common Stock
2022-12-29$10.18/sh−2,265$23,058→ 69,636 total

Footnotes (1)

[F1]This sale was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Cara Therapeutics, Inc.

CIK 0001346830

Entity typeother

Related Parties

1

filerCIK 0001756991

Filing Metadata

Form type: 4
Filed: Jan 2, 7:00 PM ET
Accepted: Jan 3, 4:32 PM ET
Size: 4.9 KB

View on SEC.gov